Macrophage functional maturation and cytokine production are impaired in C/EBP epsilon-deficient mice.
Blood., Mar;99(5):1794-801 (2002)
Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.
Blood., Nov;102(10):3727-36 (2003)
Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation.
J. Biol. Chem., Dec;278(52):52651-9 (2003)
Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes.
Blood., Dec;104(13):3911-7 (2004)
Protein partners of C/EBPepsilon.
Exp. Hematol., Dec;32(12):1173-81 (2004)
RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation.
Exp. Hematol., Apr;35(4):572-8 (2007)
The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia.
Blood., Dec;96(12):3894-9 (2000)
Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Oncogene., Jul;9(7):1899-906 (1994)
p53 transactivation through various p53-responsive elements.
Mol. Carcinog., Jun;16(2):101-8 (1996)
Molecular analysis of the INK4 family of genes in prostate carcinomas.
J. Urol., May;157(5):1995-9 (1997)
A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation.
Blood., Oct;90(7):2591-600 (1997)
Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells.
Blood., Apr;91(7):2475-81 (1998)
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
J. Clin. Invest., May;103(10):1399-408 (1999)
Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils.
Blood., Nov;94(9):3141-50 (1999)
A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors.
Clin. Cancer Res., May;16(9):2677-87 (2010)
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
Br. J. Cancer., Sep;105(6):760-5 (2011)
A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
Br. J. Cancer., Jul;91(2):344-54 (2004)
Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
Invest. Ophthalmol. Vis. Sci., Nov;46(11):3913-21 (2005)
Ossifying fibromyxoid tumor of the orbit.
Ophthal Plast Reconstr Surg., 22(2):87-91 (2006)
Minocycline for the treatment of ocular and ocular adnexal sarcoidosis.
Arch. Ophthalmol., May;125(5):705-9 (2007)